The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
Open accessAbstract
Alpha-synuclein (ASYN) is crucial in Parkinson disease (PD) pathogenesis. Increased levels of wild type (WT) ASYN expression are sufficient to cause PD in humans. The manner of post-transcriptional regulation of ASYN levels is controversial. Previously, we had shown that WT ASYN can be degraded by chaperone-mediated autophagy (CMA) in isolated liver lysosomes. Whether this occurs in a cellular and, in particular, in a neuronal cell context is unclear. Using a mutant ASYN form that lacks the CMA recognition motif and RNA interference against the rate-limiting step in the CMA pathway, Lamp2a, we show here that CMA is indeed involved in WT ASYN degradation in PC12 and SH-SY5Y cells, and in primary cortical and midbrain neurons. However, the extent of involvement varies between cell types, potentially because of differences in compensatory mechanisms. CMA inhibition leads to an accumulation of soluble high molecular weight and detergent-insoluble species of ASYN, suggesting that CMA dysfunction may play a role in the generation of such aberrant species in PD. ASYN and Lamp2a are developmentally regulated in parallel in cortical neuron cultures and in vivo in the central nervous system, and they physically interact as indicated by co-immunoprecipitation. In contrast to previous reports, inhibition of macroautophagy, but not the proteasome, also leads to WT ASYN accumulation, suggesting that this lysosomal pathway is also involved in normal ASYN turnover. These results indicate that CMA and macroautophagy are important pathways for WT ASYN degradation in neurons and underline the importance of CMA as degradation machinery in the nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [22]
In the citing paper
“dopamine-modified α-synuclein blocks chaperone-mediated autophagy [109,110], which induces abnormal intracellular accumulation α-synuclein in PD [120].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Autophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,559
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Self-citationRubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J. E., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,499
Flagged first, then by citations
Research works printed but not linked: 1
- Martinez-Vicente, 2008, J. Clin. Investig., 118, 777
Cited by
Sorted by citations
Items 301–400 of 683
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges
Arias-Carrión, Ó., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., & Manjarrez, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115405 · Cited by 51
A novel and functional variant within the ATG5 gene promoter in sporadic Parkinson's disease
Chen, D., Zhu, C., Wang, X., Feng, X., Pang, S., Huang, W., Hawley, R. G., & Yan, B. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.044 · Cited by 48
Alpha Synuclein in Parkinson’s Disease
Kragh, C. L., Romero‐Ramos, M., Halliday, G. M., & Jensen, P. H. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_14 · Cited by 48
Kim, H., Calatayud, C., Guha, S. K., Fernández‐Carasa, I., Berkowitz, L. A., Carballo‐Carbajal, I., Ezquerra, M., Fernández‐Santiago, R., Kapahi, P., Raya, Á., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0881-7 · Cited by 50
Protein Quality Control Pathways at the Crossroad of Synucleinopathies
de Mattos, E. P., Wentink, A. S., Nussbaum-Krammer, C. I., Hansen, C., Bergink, S., Melki, R., & Kampinga, H. H. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191790 · Cited by 46
Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy
Zhang, Z., Zhang, G., Sun, Y., Szeto, S. S. W., Law, H. C.-H., Quan, Q., Li, G., Yu, P., Sho, E., Siu, M. K. W., et al. (2016) · Scientific Reports · doi:10.1038/srep37148 · Cited by 45
Cui, T., Fan, C., Gu, L., Gao, H., Liu, Q., Zhang, T., Qi, Z., Zhao, C., Zhao, H., Cai, Q., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.035 · Cited by 45
Fernandes, T., Domingues, M. R., Moreira, P. I., & Pereira, C. (2023) · Biology · doi:10.3390/biology12030414 · Cited by 45
Drobny, A., Boros, F. A., Balta, D., Huarcaya, S. P., Caylioglu, D., Qazi, N., Vandrey, J., Schneider, Y., Dobert, J. P., Pitcairn, C., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00363-z · Cited by 43
Martínez‐Vicente, M., & Vila, M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.005 · Cited by 50
From cell lines to pluripotent stem cells for modelling Parkinson's Disease
Ferrari, E. S., Cardinale, A., Picconi, B., & Gardoni, F. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108741 · Cited by 46
Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
Teixeira, M., Sheta, R., Idi, W., & Oueslati, A. (2021) · Biomolecules · doi:10.3390/biom11091333 · Cited by 46
Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinsons Disease
Arduíno, D. M., Esteves, A. R., Oliveira, C. R., & Cardoso, S. M. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966687 · Cited by 44
Limegrover, C. S., Yurko, R., Izzo, N. J., LaBarbera, K. M., Rehak, C., Look, G., Rishton, G., Safferstein, H., & Catalano, S. M. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24782 · Cited by 43
Autophagy-Dependent Secretion: Contribution to Tumor Progression
Keulers, T. G., Schaaf, M. B. E., & Rouschop, K. M. A. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00251 · Cited by 43
Norwitz, N. G., Soto-Mota, A., Norwitz, S. G., & Clarke, K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00184 · Cited by 42
Hernandez, S. M., Tikhonova, E. B., & Karamyshev, A. L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00072 · Cited by 45
Zhu, J., Dou, S., Jiang, Y., Bai, B., Chen, J., Wang, C., & Cheng, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.047 · Cited by 42
Damri, O., Shemesh, N., & Agam, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010189 · Cited by 43
Zhang, G., Zhang, T., Wu, L., Zhou, X., Gu, J., Li, C., Liu, W., Long, C., Yang, X., Shan, L., et al. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8478-x · Cited by 40
Sepúlveda, D., Cisternas-Olmedo, M., Arcos, J., Nassif, M., & Vidal, R. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805087 · Cited by 42
Crabtree, D., Dodson, M. B., Ouyang, X., Boyer‐Guittaut, M., Liang, Q., Ballestas, M. E., Fineberg, N. S., & Zhang, J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12497 · Cited by 42
Greggio, E., Bisaglia, M., Civiero, L., & Bubacco, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-6 · Cited by 43
The role of the endoplasmic reticulum stress response following cerebral ischemia
Hadley, G., Neuhaus, A. A., Couch, Y., Beard, D. J., Adriaanse, B. A., Vekrellis, K., DeLuca, G. C., Papadakis, M., Sutherland, B. A., & Buchan, A. M. (2017) · International Journal of Stroke · doi:10.1177/1747493017724584 · Cited by 40
Self-citationMamais, A., Manzoni, C., Nazish, I., Arber, C., Sonustun, B., Wray, S., Warner, T. T., Cookson, M. R., Lewis, P. A., & Bandopadhyay, R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.023 · Cited by 40
Mechanisms of neuronal survival safeguarded by endocytosis and autophagy
Overhoff, M., Bruyckere, E. D., & Kononenko, N. L. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15194 · Cited by 40
Zhao, Y., & Yang, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104974 · Cited by 41
Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02472-0 · Cited by 42
Gan, M., Moussaud, S., Jiang, P., & McLean, P. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.037 · Cited by 39
Hung, K.-C., Huang, H.-J., Lin, M., Lei, Y.-P., & Lin, A. M.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091074 · Cited by 40
Chaperone-mediated autophagy as a therapeutic target for Parkinson disease
Campbell, P., Morris, H. R., & Schapira, A. H. V. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1517156 · Cited by 39
Adams, J. L., Feuerborn, M., Molina, J. A., Wilden, A. R., Adhikari, B., Budden, T., & Lee, S. Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-36379-z · Cited by 39
Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
Kang, J., Kim, J. W., Heo, H., Lee, J., Park, K. Y., Yoon, J. H., & Chang, J. (2020) · Clinical and Translational Science · doi:10.1111/cts.12920 · Cited by 39
From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and Opportunities
Mächtel, R., Boros, F. A., Dobert, J. P., Arnold, P., & Zunke, F. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167932 · Cited by 37
van der Vlag, M., Havekes, R., & Heckman, P. R. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14689 · Cited by 37
How autophagy can restore proteostasis defects in multiple diseases?
Joshi, V., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21662 · Cited by 40
Proteostasis Dysfunction in Aged Mammalian Cells. The Stressful Role of Inflammation
Ruano, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.658742 · Cited by 41
Jiang, P., Gan, M., Lin, W.-L., & Yen, S.-H. C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00268 · Cited by 39
Dou, D., Smith, E. M., Evans, C. S., Boecker, C. A., & Holzbaur, E. L. F. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112448 · Cited by 36
Diversity in the Regulation of Autophagy and Mitophagy: Lessons from Parkinson's Disease
Chu, C. T. (2011) · Parkinson s Disease · doi:10.4061/2011/789431 · Cited by 34
Protein clearing pathways in ALS.
Ferrucci, M., Fulceri, F., Toti, L., Soldani, P., Siciliano, G., Paparelli, A., & Fornai, F. (2011) · PubMed · doi:10.4449/aib.v149i1.1258 · Cited by 35
Sun, L., Lian, Y., Ding, J., Meng, Y., Li, C., Chen, L., & Qiu, P. (2019) · Brain and Behavior · doi:10.1002/brb3.1352 · Cited by 35
Soto-Rojas, L. O., Martínez-Dávila, I. A., Luna-Herrera, C., Gutiérrez-Castillo, M. E., López-Salas, F. E., Gatica-García, B., Soto-Rodríguez, G., Bringas, M. E., Flores, G., Padilla-Viveros, A., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00933-6 · Cited by 35
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity
Olsen, A. L., & Feany, M. Β. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105482 · Cited by 35
Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease
Pang, S., Chen, D., Zhang, A., Qin, X., & Yan, B. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.044 · Cited by 36
Jia, D., Zhang, L., Zhao, C., Wang, C., Huang, F.-Z., Duan, R., Xia, K., Tang, B., & Jiang, H. F. (2013) · The Cerebellum · doi:10.1007/s12311-013-0498-3 · Cited by 38
Proteostasis in neurodegenerative diseases
Kinger, S., Jagtap, Y. A., Kumar, P., Choudhary, A., Prasad, A., Prajapati, V. K., Kumar, A., Mehta, G., & Mishra, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.002 · Cited by 34
Current insights and assumptions on α-synuclein in Lewy body disease
Leak, R. K., Clark, R. N., Abbas, M., Xu, F., Brodsky, J. L., Chen, J., Hu, X., & Luk, K. C. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02781-3 · Cited by 41
A Cleaning Crew: The Pursuit of Autophagy in Parkinson’s Disease
Parekh, P., Sharma, N., Gadepalli, A., Shahane, A., Sharma, M., & Khairnar, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00244 · Cited by 34
Ardah, M. T., Ghanem, S. S., Abdulla, S. A., Lv, G., Emara, M. M., Paleologou, K. E., Vaikath, N. N., Lu, J., Li, M., Vekrellis, K., et al. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2849-1 · Cited by 34
Self-citationRetractedCrosstalk between Different DNA Repair Pathways Contributes to Neurodegenerative Diseases
Gupta, S., You, P., SenGupta, T., Nilsen, H. L., & Sharma, K. (2021) · Biology · doi:10.3390/biology10020163 · Cited by 37
Disturb mitochondrial associated proteostasis: Neurodegeneration and imperfect ageing
Jagtap, Y. A., Kumar, P., Kinger, S., Dubey, A. R., Choudhary, A., Gutti, R. K., Singh, S., Jha, H. C., Poluri, K. M., & Mishra, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146564 · Cited by 36
Zenko, D., Marsh, J., Castle, A. R., Lewin, R., Fischer, R., & Tofaris, G. K. (2023) · Science Advances · doi:10.1126/sciadv.add8910 · Cited by 36
Keane, H. A., Ryan, B. J., Jackson, B., Whitmore, A. V., & Wade‐Martins, R. (2015) · Scientific Reports · doi:10.1038/srep17004 · Cited by 33
MicroRNAs: Game Changers in the Regulation ofα-Synuclein in Parkinson’s Disease
Zhao, L., & Wang, Z. (2019) · Parkinson s Disease · doi:10.1155/2019/1743183 · Cited by 34
Autophagy in α-Synucleinopathies—An Overstrained System
Fellner, L., Gabassi, E., Haybaeck, J., & Edenhofer, F. (2021) · Cells · doi:10.3390/cells10113143 · Cited by 36
Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
Stevenson, T. J., Johnson, R. H., Savistchenko, J., Rustenhoven, J., Woolf, Z., Smyth, L. C. D., Murray, H. C., Faull, R. L. M., Correia, J. A., Schweder, P. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20261-0 · Cited by 34
Xilouri, M., Kyratzi, E., Pitychoutis, P. M., Papadopoulou-Daifoti, Z., Perier, C., Vila, M., Maniati, M., Ulusoy, A., Kirik, D., Park, D. S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr521 · Cited by 33
Self-citationHuang, Y. M., Chegini, F., Chua, G., Murphy, K., Gai, W.-P., & Halliday, G. M. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-2 · Cited by 31
Khuansuwan, S., Barnhill, L. M., Cheng, S., & Bronstein, J. M. (2019) · Autophagy · doi:10.1080/15548627.2019.1580511 · Cited by 33
Padilla-Godínez, F. J., Ramos-Acevedo, R., Martínez-Becerril, H. A., Bernal-Conde, L. D., Garrido-Figueroa, J. F., Hiriart, M., Hernández-López, A., Argüero‐Sánchez, R., Callea, F., & Guerra‐Crespo, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212467 · Cited by 33
Li, Y., Yin, Q., Wang, B., Shen, T., Luo, W., & Liu, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944376 · Cited by 32
Mus, L., Siani, F., Giuliano, C., Ghezzi, C., Cerri, S., & Blandini, F. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.001 · Cited by 32
Lee, K. I., Kim, M. J., Koh, H., Lee, J. I., Namkoong, S., Oh, W. K., & Park, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.145 · Cited by 34
Research Priorities on the Role of α‐ Synuclein in Parkinson's Disease Pathogenesis
Burré, J., Edwards, R. H., Halliday, G. M., Lang, A. E., Lashuel, H. A., Melki, R., Murayama, S., Outeiro, T. F., Papa, S. M., Stefanis, L., et al. (2024) · Movement Disorders · doi:10.1002/mds.29897 · Cited by 34
Self-citationParkinson's disease as a member of Prion-like disorders
Herva, M. E., & Spillantini, M. G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.016 · Cited by 33
Christensen, D. P., Ejlerskov, P., Rasmussen, I., & Vilhardt, F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0519-5 · Cited by 32
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 32
Protective effect of Tenuifolin against Alzheimer’s disease
Wang, L., Jin, G., Hehan, Y., Li, Q., & Yang, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.045 · Cited by 31
Ha, T.-Y., Choi, Y. R., Noh, H. R., Cha, S., Kim, J.-B., & Park, S. M. (2021) · Molecular Brain · doi:10.1186/s13041-021-00834-2 · Cited by 31
Rivero-Ríos, P., Romo-Lozano, M., Fasiczka, R., Naaldijk, Y., & Hilfiker, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00556 · Cited by 31
Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions
Kumar, S., Mehan, S., & Narula, A. S. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02272-6 · Cited by 33
Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson’s disease patients
Papagiannakis, N., Xilouri, M., Koros, C., Simitsi, A., Stamelou, M., Maniati, M., & Stefanis, L. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.003 · Cited by 33
Self-citationPitcairn, C., Murata, N., Zalon, A. J., Stojkovska, I., & Mazzulli, J. R. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0610-22.2023 · Cited by 29
Liu, M., Liu, S., Lin, Z.-H., Chen, X., Jiao, Q., Du, X., & Jiang, H. F. (2025) · Biomolecules · doi:10.3390/biom15010149 · Cited by 32
Induced pluripotent stem cell‐based modeling of mutant LRRK 2‐associated Parkinson's disease
Weykopf, B., Haupt, S., Jungverdorben, J., Flitsch, L. J., Hebisch, M., Liu, G., Suzuki, K., Belmonte, J. C. I., Peitz, M., Blaess, S., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14345 · Cited by 30
Cacciottolo, M., Nogalska, A., D’Agostino, C., Engel, W. K., & Askanas, V. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12038 · Cited by 29
Synaptic Protein Alterations in Parkinson’s Disease
Pienaar, I. S., Burn, D. J., Morris, C. M., & Dexter, D. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8226-9 · Cited by 28
Alvarez‐Castelao, B., Ruiz-Rivas, C. A., & Castaño, J. G. (2012) · Biochemistry Research International · doi:10.1155/2012/823597 · Cited by 30
Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
Kabir, M. T., Uddin, M. S., Abdeen, A., Ashraf, G. M., Perveen, A., Hafeez, A., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200618114924 · Cited by 29
Jiao, F., Meng, L., Du, K., & Li, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01195 · Cited by 30
Convergent pathways in Parkinson’s disease
Cherubini, M., & Wade‐Martins, R. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2700-2 · Cited by 28
Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02427-8 · Cited by 32
The functional roles of retromer in Parkinson's disease
Cui, Y., Yang, Z., & Teasdale, R. D. (2017) · FEBS Letters · doi:10.1002/1873-3468.12931 · Cited by 29
Fu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., & Liu, B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100053 · Cited by 29
An Update on Autophagy in Prion Diseases
López-Pérez, Ó., Badiola, J. J., Bolea, R., Ferrer, I., Llorens, F., & Martín‐Burriel, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00975 · Cited by 30
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 29
Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
Persichetti, E., Chiasserini, D., Parnetti, L., Eusebi, P., Paciotti, S., Carlo, C. D., Codini, M., Tambasco, N., Rossi, A., El‐Agnaf, O. M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101453 · Cited by 28
Batelli, S., Peverelli, E., Rodilossi, S., Forloni, G., & Albani, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.030 · Cited by 27
Huang, L., Deng, M., He, Y., Lu, S. Y., Liu, S., & Fang, Y. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.028 · Cited by 27
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 26
Selective autophagy: The new player in the fight against neurodegenerative diseases?
Wu, M.-Y., Song, J., Wang, S.-F., Cai, C.-Z., Li, M., & Lu, J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.11.009 · Cited by 27
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 27
Self-citationFričová, D., Harsányiová, J., & Trancikova, A. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228666 · Cited by 29
Ramalingam, M., Jeong, H., Hwang, J., Cho, H., Kim, B. C., Kim, E., & Jang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084193 · Cited by 28
Perez, F. P., Bandeira, J. P., Chumbiauca, C. N. P., Lahiri, D. K., Morisaki, J., & Rizkalla, M. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00825-y · Cited by 26
Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
Sanchez-Mirasierra, I., Ghimire, S., Hernández-Díaz, S., & Soukup, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.921314 · Cited by 26
Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein
Jensen, P. H., Schlossmacher, M. G., & Stefanis, L. (2023) · Movement Disorders · doi:10.1002/mds.29318 · Cited by 26
Self-citationDou, T., Matveyenka, M., & Kurouski, D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00314 · Cited by 26
Modeling proteasome dynamics in Parkinson's disease
Sneppen, K., Lizana, L., Jensen, M. H., Simone Pigolotti, A., & Otzen, D. E. (2009) · Physical Biology · doi:10.1088/1478-3975/6/3/036005 · Cited by 26
Metadata
- Authors
- Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L.
- Affiliations
- Biomedical Research Foundation of the Academy of Athens (GR)
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Stefanis, Leonidas
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 283
- Issue
- 35
- Pages
- 23542-23556
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2527094
- OpenAlex
- W2026175550
- Cited by
- 683
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 43 · 2023: 44 · 2022: 36 · 2021: 48 · 2020: 56 · 2019: 40 · 2018: 34 · 2017: 32 · 2016: 30 · 2015: 33 · 2014: 39 · 2013: 39 · 2012: 41
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R21NS055693)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- alpha-synuclein, chaperone-mediated autophagy, macroautophagy, Parkinson's disease, LAMP2A, lysosomal degradation, post-transcriptional regulation, PC12 cells, SH-SY5Y cells, cortical neurons, midbrain neurons, protein turnover
- MeSH terms
- Animals, Autophagy, Cerebral Cortex, Humans, Mesencephalon, Neurons, Parkinson Disease, PC12 Cells, Rats, Wistar, Molecular Chaperones, Mice, Rats, alpha-Synuclein, Lysosomal Membrane Proteins, Lysosomal-Associated Membrane Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
